Shares of L&T Technology Services (LTTS) rose as much as 3.6%, reaching an intraday high of ₹4,050 on the NSE after announcing a five‑year contract with Nokia to support engineering and research and development activities in India. The agreement will see LTTS establish a dedicated Offshore Development Center in India, providing data‑center‑grade compute and AI‑infrastructure engineering for next‑generation telecom solutions. The deal covers product engineering, software development, system integration and product support, as disclosed in a regulatory filing. LTTS’s share price movement reflected investor optimism over the long‑term partnership with Nokia.

On Monday, October 26, the Indian benchmark indices displayed modest gains amid a volatile session. The SENSEX surged as much as 0.5% to an intraday high of 73,491.97, while the NIFTY50 rose as much as 0.47% to touch 22,706.15. At 1:06 PM, the S&P BSE SENSEX traded flat at 73,142.64, up 18.81 points or 0.03%, and the NSE NIFTY50 stood at 22,600.55, reflecting a 0.55‑point or 0.002% increase. India VIX advanced as much as 6.7% to an intraday high of 18.

The top gainers in the NIFTY50 index included Dr. Reddy’s Laboratories, BSE Ltd, Eternal, JSW Steel and Kotak Mahindra Bank. Conversely, Shriram Finance, Tata Consumer Products, HDFC Life Insurance Company, Bajaj Finance and Asian Paints were among the top losers. Apollo Micro Systems surged 15.3% to an intraday high of ₹432 after reporting strong earnings for the July‑September quarter of FY27, with consolidated net profit rising 48.34% YoY to ₹46.15 crore and revenue up 72.3% YoY to ₹388.15 crore.

Shriram Finance’s shares fell 6.34% to an intraday low of ₹810.20 as investors noted disappointing asset quality and elevated credit costs. Nevertheless, the NBFC’s standalone profit after tax rose 59.37% YoY to ₹3,677.03 crore, and net interest income surged 38.20% YoY to ₹8,661.04 crore. Bharat Coking Coal shares climbed nearly 7% to an early market high of ₹31.80 after posting a ₹124 crore net profit in Q2 FY27, compared with a ₹53 crore loss a year earlier.

Dr. Reddy’s Laboratories stock rose 6.9% to a session peak of ₹1,314.90 despite a 31% YoY decline in consolidated net profit to ₹925 crore in Q2 FY27. Consolidated revenue stood at ₹867.08 crore, down 1.5% YoY but up 7% QoQ, with lower lenalidomide revenues in North America cited as a primary impact. The company’s performance was highlighted amid broader market volatility and sector‑specific developments.

India’s free trade agreement with the European Union, signed on January 27, 2026, is expected to be operationalised in the first quarter of 2027, according to Union Commerce Minister Piyush Goyal. Export‑oriented sectors such as textiles, gems & jewellery, leather and footwear, and marine products were in focus as the agreement may boost trade flows. Maritime stocks, including Cochin Shipyard, Garden Reach Shipbuilders & Engineers and Mazagon Dock Shipbuilders, attracted attention following Union Minister Sarbananda Sonowal’s visit to South Korea and discussions on digitalising port processes to accelerate cargo evacuation and reduce ship turnaround times.